在癌症中通过抗体介导的Claudins向
Benjamin Vonniessen1,2, Sébastien Tabariès1,2, Peter M Siegel1,2,3,4,5
1Goodman Cancer Institute, McGill University, Montréal, QC, Canada.
Frontiers in oncology
|February 19, 2024
概括
克劳是紧密结合中的关键蛋白质,对癌症的发展和传播至关重要. 针对特定克劳丁的基于抗体的疗法在癌症治疗和诊断方面表现有前途.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 紧密结节 (TJs) 保持细胞极性,其中克劳丁是关键组成部分.
- 异常的克劳丁表达与上皮癌有关,影响扩散,新陈代谢,转移和茎状.
- 克劳因正在成为各种固体癌症的预后生物标志物和治疗点.
研究的目的:
- 在癌症治疗中针对claudins的基于抗体的策略中审查最近的进展.
- 讨论针对特定类型的抗体疗法的临床前和临床开发.
- 探索新的治疗方法,如CAR-T细胞疗法和BITE用于丁向癌症治疗.
主要方法:
- 对针对Claudins的中和抗体和抗体与药物合物的临床前研究的审查 (1, 3, 4, 6, 18.2).
- 对克劳丁-6和克劳丁-18.2.2.的抗体进行评估的临床试验摘要.
- 讨论新兴策略,包括化学抗原受体 (CAR) -T细胞疗法和双特异性T细胞参与剂 (BiTEs).
主要成果:
- 临床前研究已经开发出针对Claudins 1, 3, 4, 6 和 18.2.2 的抗体和抗体-药物合体.
- 临床试验正在评估针对Claudin-6和Claudin-18.2.2.的抗体的疗效.
- 新型免疫疗法,如CAR-T细胞疗法和BiTEs正在被研究,用于克劳丁向癌症治疗.
结论:
- 克劳迪因在癌症进展中起着重要作用,是可行的治疗点.
- 基于抗体的策略,包括ADC和临床阶段抗体,显示出治疗潜力.
- 新兴的免疫疗法为向癌症治疗中的克劳丁提供了新的途径.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


